EUVIMEDEUVIMED entdecken
Leserbrief

Use of GLP ‐1 Analogues in Obesity and the Risk of Non‐Arteritic Ischaemic Optic Neuropathy: Let's Clarify!

Giovanna Muscogiuri, Annamaria Colao

Clinical Obesity · 2026-06 · 16 (3)

DOI: 10.1111/cob.70078 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Obesity, online erschienen am 03.05.2026. Verfasst von Giovanna Muscogiuri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University Federico II, Naples, Italy. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Medicine and Surgery, University Federico II, Naples, Italy.

Zitieren

APA

Muscogiuri, G., & Colao, A. (2026). Use of GLP ‐1 Analogues in Obesity and the Risk of Non‐Arteritic Ischaemic Optic Neuropathy: Let's Clarify!. Clinical Obesity, 16(3). https://doi.org/10.1111/cob.70078

Vancouver

Muscogiuri G, Colao A. Use of GLP ‐1 Analogues in Obesity and the Risk of Non‐Arteritic Ischaemic Optic Neuropathy: Let's Clarify!. Clinical Obesity. 2026;16(3). doi:10.1111/cob.70078

BibTeX
@article{Muscogiuri2026,
  author = {Muscogiuri, Giovanna and Colao, Annamaria},
  title = {Use of GLP ‐1 Analogues in Obesity and the Risk of Non‐Arteritic Ischaemic Optic Neuropathy: Let's Clarify!},
  journal = {Clinical Obesity},
  year = {2026},
  volume = {16},
  number = {3},
  doi = {10.1111/cob.70078}
}
Kostenlos starten →